The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
A Quantitative Promoter Methylation Profile of Prostate Cancer
Open accessAbstract
Purpose: Promoter hypermethylation is an alternative pathway for gene silencing in neoplastic cells and a promising cancer detection marker. Although quantitative methylation-specific PCR (QMSP) of the GSTP1 promoter has demonstrated near perfect specificity for cancer detection in prostate biopsies, we postulated that identification and characterization of additional methylation markers might further improve its high (80–90%) sensitivity. Experimental Design: We surveyed nine gene promoters (GSTP1, MGMT, p14/ARF, p16/CDKN2A, RASSF1A, APC, TIMP3, S100A2, and CRBP1) by QMSP in tissue DNA from 118 prostate carcinomas, 38 paired high-grade prostatic intraepithelial neoplasias (HGPIN), and 30 benign prostatic hyperplasias (BPH). The methylation levels were calculated and were correlated with clinical and pathologic indicators. Results: Only the methylation frequencies of GSTP1 and APC were significantly higher in prostate carcinoma compared with BPH (P < 0.001). Methylation levels of GSTP1, APC, RASSF1A, and CRBP1, differed significantly between prostate carcinoma and HGPIN, and/or HGPIN or BPH (P < 0.0001).With QMSP and empirically defined cutoff values, the combined use of GSTP1 and APC demonstrated a theoretical sensitivity of 98.3% for prostate carcinoma, with 100% specificity. Methylation levels were found to correlate with tumor grade (GSTP1 and APC) and stage (GSTP1, RASSF1A, and APC). Conclusions: Our data demonstrate the existence of a progressive increase of promoter methylation levels of several cancer-related genes in prostate carcinogenesis, providing additional markers to augment molecular detection of prostate carcinoma. Because methylation levels of GSTP1, APC, and RASSF1A are associated with advanced grade and stage, QMSP might augment the pathologic indicators currently used to predict tumor aggressiveness.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Tiwari, R. C., Murray, T., Ghafoor, A., Samuels, A., Ward, E., Feuer, E. J., & Thun, M. J. (2004) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.54.1.8 · Cited by 3,984
Gleason, D. F., Mellinger, G. T., & The Veterans Administration Cooperative Urological Research Group Members of this group areS0022534717598894-57c401330b4195dbd1713587ed540477 Lino J. Arduino Veterans Administration Center (VAC), D. M. (1974) · Journal of Urology · doi:10.1016/s0022-5347(17)59889-4 · Cited by 2,214
CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future
Esteller, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205600 · Cited by 1,233
Han, M., Partin, A. W., Pound, C. R., Epstein, J. I., & Walsh, P. C. (2001) · Urologic Clinics of North America · doi:10.1016/s0094-0143(05)70163-4 · Cited by 1,028
Emerging molecular markers of cancer
Sidransky, D. (2002) · Nature Reviews Cancer · doi:10.1038/nrc755 · Cited by 662
Self-citationEpigenetic patterns in the progression of esophageal adenocarcinoma.
Eads, C. A., Lord, R. V., Wickramasinghe, K. S., Long, T. I., Kurumboor, S. K., Bernstein, L., Peters, J. H., DeMeester, S. R., DeMeester, T. R., Skinner, K. A., et al. (2001) · PubMed · Cited by 500
Maruyama, R., Toyooka, S., Toyooka, K. O., Harada, K., Virmani, A. K., Zöchbauer‐Müller, S., Farinas, A. J., Vakar‐Lopez, F., Minna, J. D., Sagalowsky, A. I., et al. (2001) · PubMed · Cited by 422
A Modified and Improved Method for Bisulphite Based Cytosine Methylation Analysis
Olek, A., Oswald, J., & Walter, J. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.24.5064 · Cited by 376
Ahrendt, S. A., Chow, J. T., Xu, L.-H., Yang, S. C., Eisenberger, C. F., Esteller, M., Herman, J. G., Wu, L., Decker, P. A., Jen, J., et al. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.4.332 · Cited by 345
Self-citationMaruyama, R., Toyooka, S., Toyooka, K. O., et al. (2002) · PubMed · Cited by 326
Cited by
Heerboth, S., Housman, G., Leary, M., Longacre, M., Byler, S., Lapinska, K., Willbanks, A., & Sarkar, S. (2015) · Clinical and Translational Medicine · doi:10.1186/s40169-015-0048-3 · Cited by 739
Donninger, H., Vos, M. D., & Clark, G. J. (2007) · Journal of Cell Science · doi:10.1242/jcs.010389 · Cited by 440
Ogino, S., Kawasaki, T., Brahmandam, M., Cantor, M., Kirkner, G. J., Spiegelman, D., Makrigiorgos, G. M., Weisenberger, D. J., Laird, P. W., Loda, M., et al. (2006) · The Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2006.050135 · Cited by 409
Multifocal prostate cancer: biologic, prognostic, and therapeutic implications
Andreoiu, M., & Cheng, L. (2010) · Human Pathology · doi:10.1016/j.humpath.2010.02.011 · Cited by 301
The Ras-association domain family (RASSF) members and their role in human tumourigenesis
van der Weyden, L., & Adams, D. J. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2007.06.003 · Cited by 284
Metadata
- Authors
- Jerónimo, C., Henrique, R., Hoque, M. O., Mambo, E., Ribeiro, F. R., Varzim, G., Oliveira, J., Teixeira, M. R., Lopes, C., & Sidransky, D.
- Venue
- Clinical Cancer Research
- Published
- 2004-12-15
- Volume
- 10
- Issue
- 24
- Pages
- 8472-8478
- ISSN
- 1078-0432 (ISSN-L)
- 1557-3265
- OpenAlex
- W1990236447
- Cited by
- 260
- References
- 30
- FWCI
- 6.23
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Quantitative Promoter Methylation Profile of Prostate Cancer. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-04-0894
- The paper
- Jerónimo, C., Henrique, R., Hoque, M. O., Mambo, E., Ribeiro, F. R., Varzim, G., Oliveira, J., Teixeira, M. R., Lopes, C., & Sidransky, D. (2004). A Quantitative Promoter Methylation Profile of Prostate Cancer. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-04-0894
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.